Home›Companies›Healthcare›GalenusRx

GalenusRx, Inc.

Updated Oct 27, 2026·Latest SEC filing Jul 17, 2024·Suggest an edit

About GalenusRx

GalenusRx is a private company based in Fernandina Beach, Florida, incorporated in 2023 in Delaware. It has reported $6,875,647 raised in one offering on Form D since July 2024. Its chief executive is Jacques Turgeon.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Aug 30, 2023Jul 17, 2024$6,875,647of $8.0M target100$68,756EquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on GalenusRx's Form D filed Jul 17, 2024.

VM
Veronique Michaud
Executive officer and director
JT
Jacques Turgeon
Chief Executive Officer and director
OK
Orsula Knowlton
Executive officer and director
CK
Calvin Knowlton
Executive officer and director

Sources

  1. SECGalenusRx, Inc. filing history